Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Good morning and welcome to the Amneal Pharmaceuticals First Quarter 2025 Earnings Call. I’d now like to turn the call over to Amneal’s Head of ...

Second, in GLP-1s, we continue to advance our partnership with Metsera in the weight loss and obesity space, which represents a new integrated business model to drive innovation at scale in GLP-1s.

MET-097i achieved up to 11.3% mean placebo-adjusted weight loss at 12 weeks and exhibited a 380-hour (nearly 16-day) half-life and good tolerability. Metsera said the drug's profile is at least as ...

MET-097i is an ultra-long-acting GLP-1 receptor agonist that was shown in a phase 1/2 trial to achieve 7.5% weight loss over 36 days and a 380-hour (nearly 16-day) half-life, which Metsera said ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

This Is Us' star Chrissy Metz debuted her 100 lb. weight loss in May 2025. Here's everything Chrissy Metz has said about her weight loss journey.

Chrissy Metz has a new look. The actress showed off her slimmer figure in a colorful dress at Variety’s Power of Women event ...

Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion ...

Incline walking is more than just a fitness trend — it’s a science-backed, joint-friendly, and deeply effective weight loss tool. With just some km incline walking daily, paired with healthy ...